Romania is seeking to reduce the budgetary impact of a EUR 680 million payment obligation to Pfizer after losing a legal dispute over anti-COVID-19 vaccine purchases, finance minister Alexandru Nazare said, according to Economedia.ro . Nazare said the amount represents around 0.2% of Romania's GDP and poses a significant burden at a time when the government is attempting to reduce the fiscal deficit. In addition to the principal amount, interest charges continue to accumulate at a rate of approximately EUR 81,000 per day, equivalent to nearly EUR 2.5 million per month.